ContraceptionNCT04835701
Music as a Nonpharmacologic Approach to Pain Control With Intrauterine Device Placement
A study testing Music in people with Contraception, run by Icahn School of Medicine at Mount Sinai at 2 sites in United States.
Trial summary
The intervention of this study is the addition of patient-selected music during IUD insertion procedure. Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Contraception
- What is being tested?
- Music
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 8 participants
- Where
- 2 sitesUnited States
- Study dates
- 14 Dec 2020to 16 Nov 2021
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Provision of signed and dated informed consent form
- Nulliparous adult females age 18 years or older (nulliparous is defined as no prior pregnancies greater than or equal to 20 weeks of gestation)
- English-speaking patients
- Undergoing insertion of a copper or levonorgestrel intrauterine device
- Willing to comply with all study procedures
Who cannot join
- Non-English speaking patients
- Patients with a support person in the room during IUD insertion
- Patients desiring a paracervical block for analgesia
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Mount Sinai Beth Israel
New York, New York, 10003
Mount Sinai West
New York, New York, 10019
About this study
The intervention of this study is the addition of patient-selected music during IUD insertion procedure. Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure. Both control and music groups will otherwise undergo the same standard protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes.
Subjects in both control and intervention groups will undergo the same assessment of pain during IUD insertion using the 100-mm visual analog scale (VAS). This will be administered at 8 points during the procedure. All subjects will also answer the same 5-question satisfaction survey following IUD insertion. Pain scores will be measured and compared between music and control groups to assess the primary and secondary outcomes of this study.
Read the detailed description
This is a prospective, two-center, randomized controlled trial evaluating whether music reduces pain and improves satisfaction during IUD insertion. Computer-generated randomization assignments will allocate subjects to either music or standard protocol groups. 40 music and 40 control designations will be allocated to both sites, and all designations will be block-stratified into 10 blocks, each containing 4 controls and 4 intervention (music) subjects. This will ensure there are close to equal numbers of subjects in both groups if recruitment is halted before the minimum of 80 patients are enrolled. Assignments are available in a read-only document accessible by all co-investigators at the time of enrollment and randomization.
Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Both control and music groups will otherwise undergo the same standard anticipatory guidance and protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes, as is standard for an appointment for IUD insertion. Study subjects will not interact with other participants.
Patients in both control and intervention groups will undergo intrauterine device (IUD) insertion. Pain will be assessed using a 100-mm visual analog scale (VAS) at 8 points during the procedure, including: (1) anticipated pain, (2) baseline pain prior to IUD insertion, (3) after speculum placement, (4) on tenaculum application, (5) on uterine sounding, (6) at IUD insertion, (7) after speculum removal, and (8) 5 minutes following the procedure. Patients will also answer a brief 5-question satisfaction survey following IUD insertion. Pain scores will be measured and compared between music and control groups to assess the primary and secondary outcomes of this study.
VAS scores will be recorded by the attending physician or co-investigator, as they will reliably note when each step of the procedure occurs and pain should be assessed. They will present the 100mm visual analog scale (VAS) to the patient at each of the 8 points of the procedure, and the patient will mark their pain score. Scores will be measured and documented by a single co-investigator to eliminate bias or differences in measurement.
VAS scores will be analyzed separately for each of the 8 distinct points described during the IUD insertion procedure. Differences between the intervention (music) and control groups will be assessed using a 0.05 level Wilcoxon ranksum test. A significant difference in pain will be noted if at least a 20 mm difference in VAS pain score exists between the two groups at any point of the procedure when VAS score is collected.
The aim of this study is to determine if music, chosen by the patient and played during IUD insertion, leads to lower pain scores and improved patient satisfaction with the procedure.
- Conditions
- Contraception
- Being tested
- Music
- Keywords
- Intrauterine device, IUD, Pain, Music
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MusicBehavioural
Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure.
| Study group | Role | What they receive |
|---|---|---|
| Music Intervention group | Experimental | Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Participants will otherwise undergo standard protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes. Receives: Behavioral: Music |
| Control group | No intervention | Participants to undergo same standard protocol for IUD insertion in an outpatient clinic setting. No music will be played during the procedure. |
What is being measured
The primary outcome is the main question the study is designed to answer.
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, at time of IUD insertion
Secondary outcomes (7)
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, baseline prior to IUD insertion
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, after speculum placement
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, on tenaculum application
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, on uterine sounding
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, after speculum removal
100-mm visual analog scale (VAS)
100-mm VAS total scale from 1-100 with higher score indicating more pain
Measured: Day 1, 5 minutes following the procedure
Patient Satisfaction Survey
Patient Satisfaction Survey consists of 5-question administered post-procedure. Full scale from 1 to 5, with higher score indicating higher satisfaction.
Measured: Day 1, post procedure at 30 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Apr 2021
- Study start14 Dec 2020
- Primary completion16 Nov 2021
- Study completion16 Nov 2021
Why it stopped: Limited staffing support to continue screening and enrollment process
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ContraceptionStudies of the same condition, open and under way.
- More trials run by Icahn School of Medicine at Mount SinaiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 8 participants (actual)
Sponsor and investigators
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Melissa Lozano, Icahn School of Medicine at Mount Sinai
- Investigators
- Neha R Bhardwaj, MD, Principal investigator, Icahn School of Medicine at Mount Sinai
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04835701
- Sponsor's protocol ID
- IRB-20-03749
- Status last verified
- Jul 2022
- First submitted
- 5 Apr 2021
- Last updated
- 15 Jul 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No